Chugai Pharmaceutical Co. Ltd. Registered Shares o.N.
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
12.50%
Market Cap
65.39 Bil.
P/E Ratio
31.26
Dividend Yield
3.30 %
Earnings per Share
1.56 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 39.73 G | 0 Units |
| PRICE DETERMINATION TIME | 06/03/2026 / 09:56:40 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 39.82 | 39.66 |
| PREV. DAY'S PRICE | 41.03 | (06/02) |
| CHANGE DAY BEFORE | -1.30 | -3.17 % |
| 52 WEEK HIGH / LOW | 56.9 (02/27) | 34.51 (08/07) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 1.95 | 1.68 | 1.56 | 1.44 | 1.31 |
| DIVIDENDS PER SHARE | 0.85 | 0.71 | 1.61 | 0.60 | 0.53 |
| DIVIDEND YIELD IN % | - | - | 3.30 % | 1.40 % | 1.50 % |
| DIVIDEND GROWTH IN % | - | - | 169.31 % | 13.45 % | -7.11 % |
| PRICE - EARNINGS RATIO | 21.83 | 25.34 | 31.26 | 29.73 | 27.00 |
| PRICE - BOOK RATIO | - | - | 6.70 | 6.06 | 5.41 |
| PRICE - SALES RATIO | - | - | 10.78 | 9.84 | 7.91 |
| PRICE - CASH FLOW RATIO | - | - | 34.83 | 25.58 | 21.37 |
Master Data
| WKN | 857216 |
| ISIN | JP3519400000 |
| SYMBOL | CUP |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Chugai Pharmaceuticals |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Japanese Yen |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 1.65 Bil. |
| MARKET CAPITALISATION | 65.39 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -0.39 % | -11.23 % | -25.21 % | -8.00 % | -12.50 % | 60.27 % | 35.28 % | -7.98 % |
| HIGH | 42.51 | 46.01 | 54.74 | 56.90 | 56.90 | 56.90 | 56.90 | 56.90 |
| LOW | 40.30 | 40.30 | 39.81 | 39.81 | 34.51 | 24.00 | 21.80 | 39.81 |
Dividend
per share
Company profile
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.